Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May;8(5):e28.
doi: 10.1016/S2213-2600(20)30158-2. Epub 2020 Mar 26.

Antihypertensive drugs and risk of COVID-19?

Affiliations
Comment

Antihypertensive drugs and risk of COVID-19?

Joshua D Brown. Lancet Respir Med. 2020 May.
No abstract available

PubMed Disclaimer

Comment in

  • Antihypertensive drugs and risk of COVID-19?
    Lo KB, McCullough PA, Rangaswami J. Lo KB, et al. Lancet Respir Med. 2020 May;8(5):e29. doi: 10.1016/S2213-2600(20)30156-9. Epub 2020 Mar 26. Lancet Respir Med. 2020. PMID: 32222167 Free PMC article. No abstract available.
  • Antihypertensive drugs and risk of COVID-19? - Authors' reply.
    Fang L, Karakiulakis G, Roth M. Fang L, et al. Lancet Respir Med. 2020 May;8(5):e32-e33. doi: 10.1016/S2213-2600(20)30159-4. Epub 2020 Mar 26. Lancet Respir Med. 2020. PMID: 32222169 Free PMC article. No abstract available.

Comment on

References

    1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30116-8. published online March 11. - DOI - PMC - PubMed
    1. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94:e00127–e00130. - PMC - PubMed
    1. Beeftink MM, van der Sande NG, Bots ML. Safety of temporary discontinuation of antihypertensive medication in patients with difficult-to-control hypertension. Hypertension. 2017;69:927–932. - PubMed
    1. van der Wardt V, Harrison JK, Welsh T, Conroy S, Gladman J. Withdrawal of antihypertensive medication: a systematic review. J Hypertens. 2017;35:1742–1749. - PMC - PubMed
    1. Vaur L, Bobrie G, Dutrey-Dupagne C. Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients. Am J Hypertens. 1998;11:165–173. - PubMed

Substances